Invention Grant
US07794975B2 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
有权
多肽ESDN，编码多肽的多核苷酸，以及多肽的用途
- Patent Title: Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
- Patent Title (中): 多肽ESDN，编码多肽的多核苷酸，以及多肽的用途
-
Application No.: US11688170Application Date: 2007-03-19
-
Publication No.: US07794975B2Publication Date: 2010-09-14
- Inventor: Tasuku Honjo , Kei Tashiro , Kazuhiro Kobuke
- Applicant: Tasuku Honjo , Kei Tashiro , Kazuhiro Kobuke
- Applicant Address: JP Osaka
- Assignee: Ono Pharmaceutical Co., Ltd.
- Current Assignee: Ono Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Osaka
- Agency: Sughrue Mion, PLLC
- Priority: JP2001-397725 20011227
- Main IPC: C12P21/06
- IPC: C12P21/06 ; A61K38/00 ; A61K51/00
Abstract:
The invention discloses a useful and novel factor (polypeptide) which plays an important role for morbid vascular smooth muscle in restenosis after percutaneous transluminal coronany angioplasty (PTCA) and arterial sclerosis in the field of cardiovascular system.
Public/Granted literature
- US20070172892A1 NOVEL POLYPEPTIDE ESDN, POLYNUCLEOTIDES ENCODING THE POLYPEPTIDE, AND UTILITY OF THE POLYPEPTIDE Public/Granted day:2007-07-26
Information query
